Showing results (41-50 of 149) with videos related to
Sort By:
Pageof 15
Leukemia|May 1, 1996
A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemiaS Amadori, A Picardi, P Fazi, et al.Hematopathology and Molecular Hematology|January 1, 1996
Diagnosis and classification of the acute leukemias: recent advances and controversial issuesC G Taylor, R Stasi, C Bastianelli, et al.Leukemia Research|March 15, 2001
New reciprocal translocation t(6;10) (q27;q11) associated with idiopathic myelofibrosis and eosinophiliaM C Cox, P Panetta, A Venditti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphomaM Martelli, C Guglielmi, S Coluzzi, et al.Leukemia Research|January 1, 1982
Vindesine in the treatment of refractory hematologic malignancies: a phase II studyF Mandelli, S Amadori, F Giona, et al.Cancer|March 1, 1978
Lack of prognostic significance of the pretreatment labeling and mitotic indices of marrow blasts in acute nonlymphocytic leukemia (ANLL)S Amadori, M C Petti, A De Francesco, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1989
High serum interleukin-2 levels in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myelomaG Cimino, G Avvisati, S Amadori, et al.The American Journal of the Medical Sciences|April 16, 1998
Role of human leukocyte interferon-alpha in the treatment of patients with polycythemia veraR Stasi, A Venditti, G Del Poeta, et al.Leukemia Research|January 1, 1984
Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphomaS Amadori, G Papa, G Avvisati, et al.Cancer|October 1, 1987
Late multifocal gliomas in adolescents previously treated for acute lymphoblastic leukemiaM Fontana, C Stanton, A Pompili, et al.Pageof 15